Abstract
A new concept in photosensitizing tumor cells is photosensitizer synthesis in situ. Aminolevulinic acid (ALA) is a precursor of protoporphyrin IX (PP IX), a potent photosensitizer. The goal of our study was to examine dark toxicity, phototoxic potential, metabolism of ALA and morphological alterations in Waf bladder cancer cells. Dark toxicity of Waf cells was observed after incubation with ALA, beginning at a concentration of 15 mM. Photodynamic treatment with ALA at concentrations of 1,5 and 10 mM showed a drug- and light-dose-dependent cell survival rate in comparison to a control group. Two incubation times of 3.5 and 5.5 h were compared for cell survival. After a longer incubation time of 5.5 h, cell survival was decreased in all experiments; this is consistent with our extraction data where higher fluorescence was found after 5.5 than after 3.5 h. The results show that ALA-induced photosensitization has a high potential for photodynamic therapy (PDT) of superficial bladder carcinoma.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bachor R, Flotte TJ, Scholz M, Dretler S, Hasan T (1992) Comparison of intravenous and intravesical administration of chloro-aluminum sulfonated phthalocyanine for photodynamic treatment in a rat bladder cancer model. J Urol 147:1404–1410
Bedwell J, MacRobert AJ, Phillips D, Bown SG (1992) Fluorescence distribution and photodynamic effect of ALA-induced PP IX in the DMH rat colonic tumour model. Br J Cancer 65:818–824
Cairnduff F, Stringer MR, Hudson EJ, Ash DV, Brown SB (1994) Superficial photodynamic therapy with topical 5-aminolevulinic acid for superficial primary and secondary skin cancer. Br J Cancer 69: 605–608
D'Hallewin MA, Baert L, Marijnissen JPA, Star WM (1992) Whole bladder wall photodynamic therapy with in situ light dosimetry for carcinoma in situ of the bladder. J Urol 148:1152–1155
Divaris DXG, Kennedy JC, Pottier RH (1990) Phototoxic damage to sebaceous glands and hair follicles of mice after systemic administration of 5-aminolevulinic acid correlates with localized protoporphyrin IX fluorescence. Am J Pathol 136:891–897
Dougherty TJ (1978) Photosensitizers: therapy and detection of malignant tumors. Photochem Photobiol 45:879–889
Fukuda H, Battle AMC, Riley PA (1993) Kinetics of porphyrin accumulation in cultured epithelial cells exposed to ALA. Int J Biochem 25:1407–1410
Goff BA, Bachor R, Kollias N, Hasan T (1992) Effects of photodynamic therapy with topical application of 5-aminolevulinic acid on normal skin of hairless guinea pigs. J Photochem Photobiol B: Biol 15:239–251
Grant WE, Hopper C, MacRobert AJ, Speight PM, Bown SG (1993) Photodynamic therapy of oral cancer: Photosensitisation with systemic aminolevulinic acid. Lancet 342:147–148
Iinuma S, Farshi SS, OPrtel B, Hasan T (1994) A mechanistic study of cellular photodestruction with 5-aminolaevulinic acid-induced porphyrin. Br J Cancer 70: 21–28
Iinuma S, Bachor R, Flotte T, Hasan T (1995) Biodistribution and phototoxicity of 5-aminolevulinic acid-induced PP IX in an orthotropic rat bladder tumor model. J Urol 153: 802–806
Jocham D, Baumgartner R, Stepp H, Unsöld E (1990) Clinical experience with the integral photodynamic therapy of bladder carcinoma. J Photochem Photobiol B: Biol 6:183
Kennedy JC, Pottier RH, Pross DC (1990) Photodynamic therapy with endogenous protoporphyrin IX: Basic principles and present clinical experience. J Photochem Photobiol B: Biol 6:143–148
Kennedy JC, Pottier RH (1992) Endogenous protoporphyrin IX, a clinically useful photosensitizer for photodynamic therapy. J Photochem Photobiol B: Biol 14:275–292
Kriegmair M, Ehsan A, Baumgartner R, Lumper W, Knuechel R, Hofstädter F, Steinbach P, Hofstetter A (1994) Fluorescence photodetection of neoplastic urothelial lesions following intravesical instillation of 5-aminolevulinic acid. Urology 44: 836–841
Loh CS, MacRobert AJ, Bedwell J, Regula J, Krasner N, Bown SG (1993) Oral versus intravenous administration of 5-minolaevulinic acid for photodynamic therapy. Br J Cancer 68:41–51
Malik Z, Ehrenberg B, Faraggi A (1989) Inactivation of erythrocytic, lymphocytic and myelocytic leukemic cells by photoexcitation of endogenous porphyrins. J Photochem Photobiol B: Biol 4:195–205
Malik Z, Babushkina T, Shafran M, Nordenberg Y, Mamet R, Schöenfeld N (1993) Induction of protoporphyrin biosynthesis and photodynamic inactivation of B 16 melanoma cells. SPIE 2078:355–362
Manyak MJ, Russo A, Smith PD, Glatstein E (1988) Photodynamic therapy: Review article. J Clin Oncol 6:380–391
Prout GR, Lin CW, Benson R, Nseyo UO, Daly JJ, Griffin PP, Kinsey J, Tian ME, Lao YH, Mian YZ, Chen X, Ren FM, Qiao SJ (1987) Photodynamic therapy with hematoporphyrin derivative in the treatment of superficial transitional cell carcinoma of the bladder. N Engl J Med 317:1251
Rebeiz N, Rebeiz CC, Arkins S, Kelley KW, Rebeiz CA (1992) Photodestruction of tumor cells by induction of endogenous accumulation of protoporphyrin IX: Enhancement by 1,10-phenanthroline. Photochem Photobiol 55:431–435
Svanberg K, Andersson T, Killander D, Wang I, Stenram U, Andersson-Engles S, Berg R, Johansson J, Svanberg S (1994) Photodynamic therapy of non-melanoma malignant tumours of the skin using topical delta-amino-levulinic acid sensitization and laser irradiation. Br J Dermatol 130:743–751
Wolf P, Rieger E, Kerl H (1993) Topical photodynamic therapy with endogenous porphyrins after application of 5-aminolevulinic acid. J Am Acad Dermatol 28:17–21
Wolf P, Kerl H (1991) Photodynamic therapy in patient with xeroderma pigmentosum. Lancet 337:1613–1614
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bachor, R., Reich, E., Rück, A. et al. Aminolevulinic acid for photodynamic therapy of bladder carcinoma cells. Urol. Res. 24, 285–289 (1996). https://doi.org/10.1007/BF00304778
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00304778